ProLynx LLC

Basic Information

211 Belgrave Ave
San Francisco, CA, 94117-3851

Point of Contact Information

Field Value
Business Official:
Firm CFO (or equivalent):
POC Contracting Officer (or equivalent)

Additional Details

Field Value
SBC Control ID: SBC_000418168
DUNS: 831183954
CAGE: n/a
SIC Codes: n/a
NAICS Codes: n/a

Company Profile


  1. SBIR Phase I: Controlled Drug Release from and Degradation of PEG-Hydrogels

    Amount: $150,000.00

    This Small Business Innovation Research Phase I project seeks to develop novel hydrogel drug-delivery systems. We have developed linkers for drug conjugation to circulating macromolecules that release ...

    SBIR Phase I 2013 National Science Foundation
  2. Releasable site-specific attachment of macromolecules to therapeutic peptides

    Amount: $143,958.00

    DESCRIPTION (provided by applicant): Many potent and specific peptides suffer problems of short or sub-optimal duration. A possible solution to such problems involves conjugation to macromolecules suc ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Releasable attachment of drugs to PEGylated dendrimers

    Amount: $149,650.00

    DESCRIPTION (provided by applicant): We are developing a platform technology that allows predictable, controlled release of drugs from macromolecule-drug conjugates. In one current format, PEG of suff ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government